Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE715.3519.9 (+2.86 % )
PREV CLOSE (Rs.) 695.45
OPEN PRICE (Rs.) 696.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 32208
TODAY'S LOW / HIGH (Rs.)696.10 718.95
52 WK LOW / HIGH (Rs.)158.9 1025
NSE715.55 19.5 (+2.8 % )
PREV CLOSE(Rs.) 696.05
OPEN PRICE (Rs.) 697.80
BID PRICE (QTY) 715.55 (34 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 559191
TODAY'S LOW / HIGH(Rs.) 697.80 719.35
52 WK LOW / HIGH (Rs.)137.5 1026.95

Company News

Date Heading Details
24-Mar-2021 Announcement under Regulation 30 (LODR)-Newspaper Publication Filing of Public Announcement for Buyback of Fully Paid -up Equity Shares of Aarti Drugs Limited pursuant to the provisions of Regulation 7(i) of SEBI (Buyback of Securities) Regulations, 2018, as amended ('Buyback Regulation')
23-Mar-2021 Buyback Offer Inga Ventures Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a copy of Public announcement for the attention of Equity Shareholders/ Beneficial owners of Equity Shares of Aarti Drugs Ltd ("Target Company") for the Buyback of Equity Shares through a Tender Offer under Securities and Exchange Board of India (Buy Back of Securities) Regulations, 2018, as amended ("Buyback Regulations").
23-Mar-2021 Corporate Action-Updates on Buy back Please find enclosed a certified true copy of the Board Resolution dated March 19, 2021 approving the captioned Buyback, as required under Regulation 5 (vii) of the Buyback Regulations.
19-Mar-2021 Board approves Buy back of equity shares Aarti Drugs Ltd has informed BSE about Outcome of Board Meeting held on March 19, 2021.
19-Mar-2021 Outcome Of Board Meeting Held Today I.E. March 19, 2021 Of Aarti Drugs Limited ('Company') Further to our intimation dated March 16, 2021 and in terms of Regulation 30 and 42(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 9(i) of Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018, as amended ('Buyback Regulations'), we wish to inform you that the Board of Directors at its meeting held today has approved the Buyback.
19-Mar-2021 The Board Of Directors Has Determined The Record Date For The Proposed Buyback As April 1, 2021 ('Record Date'). The Board of Directors has determined the Record Date for the proposed Buyback as April 1, 2021 ('Record Date').
16-Mar-2021 Board Meeting Intimation for Buyback Of The Fully Paid-Up Equity Shares Of The Company AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/03/2021 ,inter alia, to consider and approve In compliance with Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, it is hereby informed that meeting of Board of Directors of the Company is scheduled to be held on Friday, March 19, 2021, to consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto.
16-Mar-2021 Aarti Drugs to consider share buyback proposal <p align="justify">Aarti Drugs' board is going to meet later this week to consider a share buyback proposal. A meeting of the Board of Directors of the company is scheduled to be held on Friday, March 19, 2021, to consider the proposal of buyback of the fully paid-up equity shares of the company.</p><p align="justify">Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.<br></p>
08-Mar-2021 Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find attached the press release on the approval of PLI application by Aarti Speciality Chemicals Limited, a Wholly-owned Subsidiary of Aarti Drugs Limited.